Clinical Trials Browser

OTHER × Prostatic Neoplasms × Pioglitazone × Clear all

NCT05098327 2023-08-15

Pioglitazone and Insulin Resistance in ADT

Phase 3 Withdrawn

Diabetes Mellitus, Type 2, Insulin Resistance, Prostatic Neoplasms

NCT04995978 2023-06-23

Insulin Resistance and Androgen Deprivation Therapy

Phase 2 Withdrawn

Insulin Resistance, Prostatic Neoplasms

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

Phase EARLY_PHASE1 Withdrawn

Insulin Resistance, Prostatic Neoplasms